Purity, potency, and safety – affordably – in stem cell therapy
11.06.2024
0:00
28:25
In a new episode of the pharmaphorum podcast, web editor Nicole Raleigh discusses stem cell therapy, and accessibility to and affordability of such treatment, with Rafael R Carazo Salas, founder and CEO of CellVoyant, an AI-first biotechnology company spun out from the University of Bristol.
Więcej odcinków z kanału "pharmaphorum Podcast"
Nie przegap odcinka z kanału “pharmaphorum Podcast”! Subskrybuj bezpłatnie w aplikacji GetPodcast.